Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma

Chan A.T.C.MOW-MING HSUGoh B.C.Hui E.P.Liu T.-W.Millward M.J.RUEY-LONG HONGWhang-Peng J.Ma B.B.Y.To K.F.Mueser M.Amellal N.Lin X.Chang A.Y.2021-03-092021-03-0920050732-183Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-20644435370&doi=10.1200%2fJCO.2005.02.147&partnerID=40&md5=d1e5fc291d8bf3de5572bfa62259acd0https://scholars.lib.ntu.edu.tw/handle/123456789/551260[SDGs]SDG3Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinomajournal article10.1200/JCO.2005.02.147158094532-s2.0-20644435370